Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$11.13 USD
+0.10 (0.91%)
Updated Aug 8, 2024 01:15 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Brokerage Reports
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 81 - 100 ( 132 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Week - Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis State of the Union: A Year of Resiliency With Focus on 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: 280E Removal Would Bring More Than Just Financial Leverage
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly Rehash: U.S. Interstate Commerce the Long Game
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Industry Preserving Cash in Prep for a Nuclear Winter
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Scoring the MSOs with Cash Flow, Debt and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Pricing is Key to Improving Industry Fundamentals
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Putting 2022 Performance & Valuations Behind Us
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Initiating Coverage of U.S. Cannabis: Setting Stage for Greener Pastures
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Initiating Coverage at Outperform: Green Light for Green Thumb
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Update: NY Regulations a Different Framework, Verticality Challenged
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: 3Q Cannabis Earnings Recap, Inflationary Pressures Impacting NT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: Earnings Week II Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Mid-Term Election Impact on Cannabis Adding New Adult-Use States
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Solid Beat to Consensus and the Pipeline Remains Packed; Moderating Estimates on Economic Outlook, and PT to C$40/shr
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q22 Earnings - Week I Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department